Syngenta increased global sales by 6% to $11.6bn (£7.2bn) last year, on the back of strong demand in emerging markets.
The company’s 2010 results showed operating income was maintained at $1.97bn (£1.2bn), while earnings before interest, taxes, depreciation and amortisation (EBITDA) increased by 3% to $2.5bn (£1.5bn).
Sales had almost doubled since the firm’s creation ten years ago, chief executive Mike Mack said. Expansion had been particularly rapid in emerging markets, such as Asia and Brazil, which now accounted for almost 50% of sales.
“As we enter 2011, we expect market share growth and expansion in emerging markets to support volume momentum as we implement our new commercial strategy,” he said.